UB Paderborn / Katalog / Suche / in CDI

1 – 11 von 11

Sortiert nach

Decreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study

PSYCHIATRY INVESTIGATION, 2017, 14(3), , pp.344-349

2017

Volltextzugriff (PDF)

Total Tau and Phosphorylated Tau Protein Serum Levels in Patients with Schizophrenia Compared with Controls

Psychiatric quarterly, 2017-12, Vol.88 (4), p.921-928

2017

Volltextzugriff (PDF)

Minor physical anomalies and neurological soft signs in patients with schizophrenia and their siblings

Psychiatry research, 2011-11, Vol.190 (1), p.85-90

2011

Volltextzugriff (PDF)

Clinical and cognitive insight in patients with acute-phase psychosis: Association with treatment and neuropsychological functioning

Nordic journal of psychiatry, 2016-10, Vol.70 (7), p.528-535

2016

Volltextzugriff (PDF)

Electrocardiographical P wave changes after electroconvulsive therapy in patients with schizophrenia: a preliminary study

The journal of ECT, 2009-03, Vol.25 (1), p.26

2009

Volltextzugriff (PDF)

Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia

Psychiatric quarterly, 2016-06, Vol.87 (2), p.315-322

2016

Volltextzugriff (PDF)

Clozapine use in two women with schizophrenia during pregnancy

Journal of psychopharmacology (Oxford), 2008, Vol.22 (1), p.111-113

2008

Volltextzugriff (PDF)

Case Report: Clozapine use in two women with schizophrenia during pregnancy

Journal of psychopharmacology (Oxford), 2008-01, Vol.22 (1), p.111-113

2008

Volltextzugriff (PDF)

Sizofreni Hastalarinin Etkilenmemis Birinci Derece Yakinlarindaki Sizotipal Özelliklerin Saglikli Bireylerle Karsilastirilmasi: Bir Ön Çalisma

Klinik psikofarmakoloji bülteni, 2007, Vol.17 (4), p.181

2007

Volltextzugriff (PDF)

Plasma G72 protein in schizophrenia: A comparative analysis of drug-naive schizophrenia patients, patients in acute exacerbation and healthy controls

Journal of psychiatric research, 2024-10, Vol.178, p.8-14

2024

Volltextzugriff (PDF)

Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity

Psychiatry and clinical psychopharmacology, 2019-10, Vol.29 (4), p.394-398

2019

Volltextzugriff (PDF)

1 – 11 von 11

Suche als RSS-Feed

Aktive Filter

ThemaSchizophrenia

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(11)

Sprache

Englisch
(10)
Türkisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Decreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study

Total Tau and Phosphorylated Tau Protein Serum Levels in Patients with Schizophrenia Compared with Controls

Minor physical anomalies and neurological soft signs in patients with schizophrenia and their siblings

Clinical and cognitive insight in patients with acute-phase psychosis: Association with treatment and neuropsychological functioning

Electrocardiographical P wave changes after electroconvulsive therapy in patients with schizophrenia: a preliminary study

Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia

Clozapine use in two women with schizophrenia during pregnancy

Case Report: Clozapine use in two women with schizophrenia during pregnancy

Sizofreni Hastalarinin Etkilenmemis Birinci Derece Yakinlarindaki Sizotipal Özelliklerin Saglikli Bireylerle Karsilastirilmasi: Bir Ön Çalisma

Plasma G72 protein in schizophrenia: A comparative analysis of drug-naive schizophrenia patients, patients in acute exacerbation and healthy controls

Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity

Aktive Filter

Suchergebnisse filtern